{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-25-000354","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2025-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.899209+00:00","generated_at":"2026-05-25T05:54:36.811809+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Renovaro Extends LOI with Predictive Oncology, Acquires Shares for $500,000","bullets":["Renovaro and Predictive Oncology extended the LOI termination date from February 28, 2025 to March 31, 2025.","Renovaro acquired 467,290 shares of Predictive Oncology common stock for $500,000 at $1.07 per share.","Renovaro agreed to purchase an additional 901,298 shares for $964,389 upon execution of a definitive merger agreement.","The amendment eliminated Renovaro's obligation to acquire certain shares under the original warrant exercise provision."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-25-000354","json":"https://secwatch.observer/filing/0001731122-25-000354.json","markdown":"https://secwatch.observer/filing/0001731122-25-000354.md","text":"https://secwatch.observer/filing/0001731122-25-000354.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000354/0001731122-25-000354-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000354/e6404_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-25T05:54:36.811809+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}